Literature DB >> 26413228

Lean heart: Role of leptin in cardiac hypertrophy and metabolism.

Michael E Hall1, Romain Harmancey1, David E Stec1.   

Abstract

Leptin is an adipokine that has been linked with the cardiovascular complications resulting from obesity such as hypertension and heart disease. Obese patients have high levels of circulating leptin due to increased fat mass. Clinical and population studies have correlated high levels of circulating leptin with the development of cardiac hypertrophy in obesity. Leptin has also been demonstrated to increase the growth of cultured cardiomyocytes. However, several animal studies of obese leptin deficient mice have not supported a role for leptin in promoting cardiac hypertrophy so the role of leptin in this pathological process remains unclear. Leptin is also an important hormone in the regulation of cardiac metabolism where it supports oxidation of glucose and fatty acids. In addition, leptin plays a critical role in protecting the heart from excess lipid accumulation and the formation of toxic lipids in obesity a condition known as cardiac lipotoxicity. This paper focuses on the data supporting and refuting leptin's role in promoting cardiac hypertrophy as well as its important role in the regulation of cardiac metabolism and protection against cardiac lipotoxicity.

Entities:  

Keywords:  Cardiotoxicity; Diabetes; Leptin; Leptin receptor; Lipotoxicity; Obesity

Year:  2015        PMID: 26413228      PMCID: PMC4577678          DOI: 10.4330/wjc.v7.i9.511

Source DB:  PubMed          Journal:  World J Cardiol


  105 in total

1.  Role of the sympathetic nervous system and insulin in enhancing glucose uptake in peripheral tissues after intrahypothalamic injection of leptin in rats.

Authors:  M S Haque; Y Minokoshi; M Hamai; M Iwai; M Horiuchi; T Shimazu
Journal:  Diabetes       Date:  1999-09       Impact factor: 9.461

2.  Restoration of glucose metabolism in leptin-resistant mouse hearts after acute myocardial infarction through the activation of survival kinase pathways.

Authors:  William Witham; Keith Yester; Christopher P O'Donnell; Kenneth R McGaffin
Journal:  J Mol Cell Cardiol       Date:  2012-04-06       Impact factor: 5.000

3.  Chronic leptin infusion increases arterial pressure.

Authors:  E W Shek; M W Brands; J E Hall
Journal:  Hypertension       Date:  1998-01       Impact factor: 10.190

4.  High leptin and resistin expression in chronic heart failure: adverse outcome in patients with dilated and inflammatory cardiomyopathy.

Authors:  Peter Bobbert; Alexander Jenke; Thomas Bobbert; Uwe Kühl; Ursula Rauch; Dirk Lassner; Carmen Scheibenbogen; Wolfgang Poller; Heinz-Peter Schultheiss; Carsten Skurk
Journal:  Eur J Heart Fail       Date:  2012-07-04       Impact factor: 15.534

5.  A critical role for eukaryotic elongation factor 1A-1 in lipotoxic cell death.

Authors:  Nica M Borradaile; Kimberly K Buhman; Laura L Listenberger; Carolyn J Magee; Emiko T A Morimoto; Daniel S Ory; Jean E Schaffer
Journal:  Mol Biol Cell       Date:  2005-11-30       Impact factor: 4.138

Review 6.  Leptin and the clinical cardiovascular risk.

Authors:  Mukesh Singh; Updesh S Bedi; Param P Singh; Rohit Arora; Sandeep Khosla
Journal:  Int J Cardiol       Date:  2009-11-27       Impact factor: 4.164

7.  Insulin-like effect of low-dose leptin on glucose transport in Langendorff rat hearts.

Authors:  M Haap; B Houdali; E Maerker; W Renn; F Machicao; H M Hoffmeister; H-U Häring; K Rett
Journal:  Exp Clin Endocrinol Diabetes       Date:  2003-05       Impact factor: 2.949

Review 8.  Diabetic cardiomyopathy revisited.

Authors:  Sihem Boudina; E Dale Abel
Journal:  Circulation       Date:  2007-06-26       Impact factor: 29.690

9.  Rat heart is a site of leptin production and action.

Authors:  Daniel M Purdham; Min-Xu Zou; Venkatesh Rajapurohitam; Morris Karmazyn
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-07-29       Impact factor: 4.733

10.  Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models.

Authors:  Norimichi Koitabashi; Djahida Bedja; Ari L Zaiman; Yigal M Pinto; Manling Zhang; Kathleen L Gabrielson; Eiki Takimoto; David A Kass
Journal:  Circ Res       Date:  2009-06-11       Impact factor: 17.367

View more
  24 in total

Review 1.  Novel methods in pulmonary hypertension phenotyping in the age of precision medicine (2015 Grover Conference series).

Authors:  Jarrod W Barnes; Adriano R Tonelli; Gustavo A Heresi; Jennie E Newman; Noël E Mellor; David E Grove; Raed A Dweik
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

2.  Age-dependent development of left ventricular wall thickness in type 2 diabetic (db/db) mice is associated with elevated low-density lipoprotein and triglyceride serum levels.

Authors:  Phiwayinkosi V Dludla; M Faadiel Essop; Kwazi B Gabuza; Christo J F Muller; Johan Louw; Rabia Johnson
Journal:  Heart Vessels       Date:  2017-04-09       Impact factor: 2.037

Review 3.  Adiponectin, Leptin and Cardiovascular Disorders.

Authors:  Shangang Zhao; Christine M Kusminski; Philipp E Scherer
Journal:  Circ Res       Date:  2021-01-07       Impact factor: 17.367

Review 4.  Effect of Leptin on Chronic Inflammatory Disorders: Insights to Therapeutic Target to Prevent Further Cardiovascular Complication.

Authors:  Gashaw Dessie; Birhanu Ayelign; Yonas Akalu; Tewodros Shibabaw; Meseret Derbew Molla
Journal:  Diabetes Metab Syndr Obes       Date:  2021-07-17       Impact factor: 3.168

Review 5.  Pathophysiology of Non Alcoholic Fatty Liver Disease.

Authors:  Salvatore Petta; Amalia Gastaldelli; Eleni Rebelos; Elisabetta Bugianesi; Piergiorgio Messa; Luca Miele; Gianluca Svegliati-Baroni; Luca Valenti; Ferruccio Bonino
Journal:  Int J Mol Sci       Date:  2016-12-11       Impact factor: 5.923

Review 6.  Long Non-Coding RNAs in Metabolic Organs and Energy Homeostasis.

Authors:  Maude Giroud; Marcel Scheideler
Journal:  Int J Mol Sci       Date:  2017-11-30       Impact factor: 5.923

7.  Cardiac leptin overexpression in the context of acute MI and reperfusion potentiates myocardial remodeling and left ventricular dysfunction.

Authors:  David Kain; Amos J Simon; Avraham Greenberg; Danny Ben Zvi; Boris Gilburd; Jacob Schneiderman
Journal:  PLoS One       Date:  2018-10-12       Impact factor: 3.240

8.  Associations of adiponectin and leptin with brain natriuretic peptide in African Americans: the Jackson Heart Study.

Authors:  Steven R Horbal; Michael E Hall; Paul C Dinh; Abbas Smiley; Solomon K Musani; Jiankang Liu; Herman A Taylor; Ervin R Fox; Aurelian Bidulescu
Journal:  Cardiovasc Endocrinol Metab       Date:  2020-05-15

Review 9.  Role of Leptin in Cardiovascular Diseases.

Authors:  Mareike S Poetsch; Anna Strano; Kaomei Guan
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-16       Impact factor: 5.555

10.  MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin.

Authors:  Beibei Dai; Huaping Li; Jiahui Fan; Yanru Zhao; Zhongwei Yin; Xiang Nie; Dao Wen Wang; Chen Chen
Journal:  Cardiovasc Diabetol       Date:  2018-09-04       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.